September 9, 1974

Amphetamines and Malignant LymphomaA Report From the Boston Collaborative Drug Surveillance Program

JAMA. 1974;229(11):1462-1463. doi:10.1001/jama.1974.03230490050023

The relationship of exposure to amphetamines and malignant lymphoma was evaluated using data collected by the Boston Collaborative Drug Surveillance Program. Of the 315 patients with this diagnosis, none gave a history of exposure to amphetamines, while among 38,900 control subjects 218 (0.56%) gave such a history. These findings do not lend support to the recently published hypothesis of an association between amphetamine usage and Hodgkin disease.

(JAMA 229:1462-1463, 1974)